These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30917629)

  • 1. Oral iron supplementation with Feralgine® in inflammatory bowel disease: a retrospective observational study.
    Vernero M; Boano V; Ribaldone DG; Pellicano R; Astegiano M
    Minerva Gastroenterol Dietol; 2019 Sep; 65(3):200-203. PubMed ID: 30917629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
    Schröder O; Mickisch O; Seidler U; de Weerth A; Dignass AU; Herfarth H; Reinshagen M; Schreiber S; Junge U; Schrott M; Stein J
    Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement.
    Gisbert JP; Bermejo F; Pajares R; Pérez-Calle JL; Rodríguez M; Algaba A; Mancenido N; de la Morena F; Carneros JA; McNicholl AG; González-Lama Y; Maté J
    Inflamm Bowel Dis; 2009 Oct; 15(10):1485-91. PubMed ID: 19408339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Efficacies of Parenteral Iron Sucrose and Oral Iron Sulfate for Anemic Patients with Inflammatory Bowel Disease in Korea.
    Han YM; Yoon H; Shin CM; Koh SJ; Im JP; Kim BG; Kim JS; Jung HC
    Gut Liver; 2016 Jul; 10(4):562-8. PubMed ID: 27021505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sucrosomial Iron Supplementation for the Treatment of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients Refractory to Oral Iron Treatment.
    Bastida G; Herrera-de Guise C; Algaba A; Ber Nieto Y; Soares JM; Robles V; Bermejo F; Sáez-González E; Gomollón F; Nos P
    Nutrients; 2021 May; 13(6):. PubMed ID: 34067320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED).
    Reinisch W; Staun M; Tandon RK; Altorjay I; Thillainayagam AV; Gratzer C; Nijhawan S; Thomsen LL
    Am J Gastroenterol; 2013 Dec; 108(12):1877-88. PubMed ID: 24145678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Oral Supplementation with Liposomal Iron in Non-Dialysis Chronic Kidney Disease Patients with Iron Deficiency.
    Cesarano D; Borrelli S; Campilongo G; D'Ambra A; Papadia F; Garofalo C; De Marco A; Marzano F; Ruotolo C; Gesualdo L; Cirillo P; Minutolo R
    Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Iron Treatment Response and Predictors in Anaemic Adolescents and Adults with IBD: A Prospective Controlled Open-Label Trial.
    Rampton DS; Goodhand JR; Joshi NM; Karim AB; Koodun Y; Barakat FM; Macken L; Ward DG; Iqbal TH; Epstein J; Fell JM; Sanderson IR
    J Crohns Colitis; 2017 Jun; 11(6):706-715. PubMed ID: 27932449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy and Safety of Vitamin C for Iron Supplementation in Adult Patients With Iron Deficiency Anemia: A Randomized Clinical Trial.
    Li N; Zhao G; Wu W; Zhang M; Liu W; Chen Q; Wang X
    JAMA Netw Open; 2020 Nov; 3(11):e2023644. PubMed ID: 33136134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactoferrin for iron-deficiency anemia in children with inflammatory bowel disease: a clinical trial.
    El Amrousy D; El-Afify D; Elsawy A; Elsheikh M; Donia A; Nassar M
    Pediatr Res; 2022 Sep; 92(3):762-766. PubMed ID: 35681097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of oral ferrous bisglycinate supplementation on hemoglobin and ferritin concentrations in adults and children: a systematic review and meta-analysis of randomized controlled trials.
    Fischer JAJ; Cherian AM; Bone JN; Karakochuk CD
    Nutr Rev; 2023 Jul; 81(8):904-920. PubMed ID: 36728680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia in Pediatric Inflammatory Bowel Disease.
    Stein RE; Plantz K; Maxwell EC; Mamula P; Baldassano RN
    J Pediatr Gastroenterol Nutr; 2018 Feb; 66(2):e51-e55. PubMed ID: 28704225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaemia management in patients with inflammatory bowel disease: routine practice across nine European countries.
    Stein J; Bager P; Befrits R; Gasche C; Gudehus M; Lerebours E; Magro F; Mearin F; Mitchell D; Oldenburg B; Danese S
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1456-63. PubMed ID: 24100539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease.
    Beigel F; Löhr B; Laubender RP; Tillack C; Schnitzler F; Breiteneicher S; Weidinger M; Göke B; Seiderer J; Ochsenkühn T; Brand S
    Digestion; 2012; 85(1):47-54. PubMed ID: 22179489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.
    Evstatiev R; Marteau P; Iqbal T; Khalif IL; Stein J; Bokemeyer B; Chopey IV; Gutzwiller FS; Riopel L; Gasche C;
    Gastroenterology; 2011 Sep; 141(3):846-853.e1-2. PubMed ID: 21699794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of iron deficiency anemia with liposomal iron in inflammatory bowel disease: efficacy and impact on quality of life.
    de Alvarenga Antunes CV; de Alvarenga Nascimento CR; Campanha da Rocha Ribeiro T; de Alvarenga Antunes P; de Andrade Chebli L; Martins Gonçalves Fava L; Malaguti C; Maria Fonseca Chebli J
    Int J Clin Pharm; 2020 Jun; 42(3):895-902. PubMed ID: 32367457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of C-reactive protein levels in predicting responsiveness to iron therapy in patients with inflammatory bowel disease and iron deficiency anemia.
    Iqbal T; Stein J; Sharma N; Kulnigg-Dabsch S; Vel S; Gasche C
    Dig Dis Sci; 2015 May; 60(5):1375-81. PubMed ID: 25501922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron Supplementation, Response in Iron-Deficiency Anemia: Analysis of Five Trials.
    Okam MM; Koch TA; Tran MH
    Am J Med; 2017 Aug; 130(8):991.e1-991.e8. PubMed ID: 28454902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between thrombocytosis and iron deficiency anemia in inflammatory bowel disease.
    Voudoukis E; Karmiris K; Oustamanolakis P; Theodoropoulou A; Sfiridaki A; Paspatis GA; Koutroubakis IE
    Eur J Gastroenterol Hepatol; 2013 Oct; 25(10):1212-6. PubMed ID: 23839158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment.
    Kulnigg S; Teischinger L; Dejaco C; Waldhör T; Gasche C
    Am J Gastroenterol; 2009 Jun; 104(6):1460-7. PubMed ID: 19491860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.